article A single approach to creating effective cancer and autoimmune disease therapeutics 8 January 2021 | By Dr H Michael Shepard (Enosi Life Sciences) Dr H. Michael Shepard, CEO and CSO of Enosi Life Sciences, discusses the similarities between cancer and autoimmune diseases, highlighting how this knowledge could be used to enhance treatments.
news Exploration of autoimmune disease target tissues reveals novel drug targets 7 January 2021 | By Hannah Balfour (Drug Target Review) Researchers suggest that identifying new treatments for autoimmune diseases requires studying the immune system AND target tissues together.
news Targeting innate immunity with Transcreener® Assays 25 June 2020 | By BellBrook Labs Over the past year, BellBrook Labs has leveraged its Transcreener HTS Assay technology to build enabling products and services focusing on innate immunity targets.
article Could novel sex-linked targets provide an autoimmunity therapy? 20 January 2020 | By Hannah Balfour (Drug Target Review) Recent research into why autoimmune disorders affect women four times more frequently than men has revealed several novel therapeutic targets that may lead to the development of future treatments.